fingolimod hydrochloride has been researched along with Dysplastic Nevus Syndrome, Hereditary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carbone, ML; De Giglio, L; Failla, CM; Lacal, PM; Mazzanti, C; Messinese, S; Pagnanelli, G; Persechino, S; Pozzilli, C | 1 |
| Haebich, G; Mughal, A; Tofazzal, N | 1 |
| Guo, M; Robinson, CL | 1 |
1 review(s) available for fingolimod hydrochloride and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Multiple Sclerosis Treatment and Melanoma Development.
Topics: Antirheumatic Agents; Biomarkers; Biopsy; Disease Susceptibility; Female; Fingolimod Hydrochloride; Humans; Immunohistochemistry; Immunosuppressive Agents; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multiple Sclerosis; Natalizumab; Skin Neoplasms; Vascular Endothelial Growth Factor A | 2020 |
2 other study(ies) available for fingolimod hydrochloride and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
Topics: Adult; Ankle; Female; Fingolimod Hydrochloride; Humans; Melanoma; Melanoma, Cutaneous Malignant; Multiple Sclerosis, Relapsing-Remitting; Skin Neoplasms | 2016 |
Fingolimod (Gilenya) and melanoma.
Topics: Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multiple Sclerosis; Skin Neoplasms | 2016 |